Papillary thyroid carcinoma behavior: clues in the tumor microenvironment.


Journal

Endocrine-related cancer
ISSN: 1479-6821
Titre abrégé: Endocr Relat Cancer
Pays: England
ID NLM: 9436481

Informations de publication

Date de publication:
06 2019
Historique:
received: 01 04 2019
accepted: 09 04 2019
pubmed: 10 4 2019
medline: 23 7 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

The prevalence of thyroid carcinoma is increasing and represents the most common endocrine malignancy, with papillary thyroid carcinoma (PTC) being the most frequent subtype. The genetic alterations identified in PTCs fail to distinguish tumors with different clinical behaviors, such as extra-thyroidal extension and lymph node metastasis. We hypothesize that the immune microenvironment may play a critical role in tumor invasion and metastasis. Computational immunogenomic analysis was performed on 568 PTC samples in The Cancer Genome Atlas using CIBERSORT, TIMER and TIDE deconvolution analytic tools for characterizing immune cell composition. Immune cell infiltrates were correlated with histologic type, mutational type, tumor pathologic T stage and lymph node N stage. Dendritic cells (DCs) are highly associated with more locally advanced tumor T stage (T3/T4, odds ratio (OR) = 2.6, CI = 1.4-4.5, P = 5.4 × 10-4). Increased dendritic cells (OR = 3.4, CI = 1.9-6.3, P = 5.5 × 10-5) and neutrophils (OR = 10.5, CI = 2.7-44, P = 8.7 × 10-4) significantly correlate with lymph node metastasis. In addition, dendritic cells positively correlate with tall cell morphology (OR = 4.5, CI = 1.6-13, P = 4.9 × 10-3) and neutrophils negatively correlate with follicular morphology (OR = 1.3 × 10-3, CI = 5.3 × 10-5-0.031, P = 4.1 × 10-5). TIDE analysis indicates an immune-exclusive phenotype that may be mediated by increased galectin-3 found in PTCs. Thus, characterization of the PTC immune microenvironment using three computational platforms shows that specific immune cells correlate with mutational type, histologic type, local tumor extent and lymph node metastasis. Immunologic evaluation of PTCs may provide a better indication of biologic behavior, resulting in the improved diagnosis and treatment of thyroid cancer.

Identifiants

pubmed: 30965283
doi: 10.1530/ERC-19-0074
pii: ERC-19-0074.R1
pmc: PMC8279427
mid: NIHMS1712865
doi:
pii:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

601-614

Subventions

Organisme : NIH HHS
ID : S10 OD023475
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK059637
Pays : United States

Références

Endocrinol Metab (Seoul). 2013 Sep;28(3):178-9
pubmed: 24396676
Am J Pathol. 2010 May;176(5):2067-81
pubmed: 20363921
Cancer Res. 2017 Nov 1;77(21):e108-e110
pubmed: 29092952
Thyroid. 2017 Nov;27(11):1347-1359
pubmed: 28891394
Carcinogenesis. 2014 Aug;35(8):1780-7
pubmed: 24608042
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Nature. 2015 Dec 17;528(7582):413-7
pubmed: 26649828
Genome Biol. 2016 Aug 22;17(1):174
pubmed: 27549193
Genes Immun. 2005 Jun;6(4):319-31
pubmed: 15789058
Cancer. 2006 Feb 1;106(3):524-31
pubmed: 16369995
Endocr Relat Cancer. 2018 May;25(5):523-531
pubmed: 29507047
PLoS One. 2018 Jun 28;13(6):e0199740
pubmed: 29953504
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102
pubmed: 28407145
Thyroid. 2014 Feb;24(2):339-46
pubmed: 23915122
J Pathol Transl Med. 2015 Jul;49(4):318-24
pubmed: 26081823
J Invest Dermatol. 2018 Jul;138(7):1627-1635
pubmed: 29474942
BMC Immunol. 2018 Apr 16;19(1):13
pubmed: 29661142
Endocr Relat Cancer. 2008 Dec;15(4):1069-74
pubmed: 18719091
Front Endocrinol (Lausanne). 2018 Jun 21;9:314
pubmed: 29977225
Nat Commun. 2017 Oct 6;8(1):793
pubmed: 28986561
J Clin Endocrinol Metab. 1995 Dec;80(12):3421-4
pubmed: 8530576
Thyroid. 2012 Sep;22(9):905-10
pubmed: 22870901
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Cancers (Basel). 2018 Dec 05;10(12):
pubmed: 30563160
Cancer Res. 2004 Aug 15;64(16):5535-8
pubmed: 15313886
Adv Anat Pathol. 2017 Nov;24(6):311-335
pubmed: 28777143
Immunity. 2011 Nov 23;35(5):671-80
pubmed: 22118524
Adv Anat Pathol. 2017 Sep;24(5):235-251
pubmed: 28777142
J Clin Invest. 2013 Jul;123(7):2873-92
pubmed: 23778140
Clin Endocrinol (Oxf). 2012 Dec;77(6):918-25
pubmed: 22738343
Endocrine. 2013 Aug;44(1):172-81
pubmed: 23264145
JAMA Oncol. 2016 Aug 1;2(8):1023-9
pubmed: 27078145
J Pathol. 2005 Apr;205(5):565-76
pubmed: 15714595
Nat Med. 2018 Oct;24(10):1550-1558
pubmed: 30127393
Oncoimmunology. 2016 Mar 30;5(6):e1168556
pubmed: 27471646
Oncoimmunology. 2013 Oct 1;2(10):e26066
pubmed: 24244900
Clin Cancer Res. 2004 Nov 15;10(22):7466-74
pubmed: 15569976
Cancer Immunol Res. 2015 Apr;3(4):412-23
pubmed: 25691328
J Clin Endocrinol Metab. 2010 May;95(5):2325-33
pubmed: 20207826
Nature. 2015 Jun 18;522(7556):345-348
pubmed: 25822788
Nat Rev Immunol. 2011 Dec 09;12(1):24-34
pubmed: 22158414
Clin Endocrinol (Oxf). 2015 Aug;83(2):246-53
pubmed: 25130519
PLoS Med. 2016 Dec 13;13(12):e1002194
pubmed: 27959923
J Transl Med. 2008 Apr 22;6:19
pubmed: 18430198
J Natl Cancer Inst. 2016 Oct 13;109(1):
pubmed: 27737921
Immunol Rev. 2016 May;271(1):260-75
pubmed: 27088920

Auteurs

Kensey Bergdorf (K)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Donna C Ferguson (DC)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Mitra Mehrad (M)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Kim Ely (K)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Thomas Stricker (T)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Vivian L Weiss (VL)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH